All News

The study in BMJ found that people with the FTO gene were just as likely to lose weight through interventions, such as diet, exercise, or therapy.

A new study published in the journal PLoS Medicine has found strong evidence that a significant portion of information on adverse events, gathered from clinical trials, remains unpublished.

Most efforts to reduce low-value care have so far been focused on areas where there is general agreement, and more discussions are needed to reach a consensus on additional aspects of care that are considered low value.

What we're reading, September 21, 2016: Missouri law to charge Medicaid patients for missed doctor's appointments is in limbo; generic drugs' potential to bring down costs; fitness trackers cause people to lose less weight.

Colombia has decided to slash the price of imatinib mesylate (Gleevec), manufactured by Novartis, by nearly half.

People who visit the emergency department (ED) for mental health care are transferred to another facility at a rate 6 times higher than people who visit EDs for non-psychiatric conditions, and they wait hours longer, as well

The National Cancer Institute's Cancer Moonshot initiative received yet another boost following Vice President Joe Biden’s announcement of several activities to accelerate the pace of oncology clinical research.

While obesity is a known risk factor in gestational diabetes, women who were obese and also were depressed when they became pregnant were at greater risk of gestational diabetes than those who did not have depression.

The dispute between the ACLU and Colorado Medicaid has been seen in other states and with other payers. Policy questions on treatment for hepatitis C virus were examined in a special issue of The American Journal of Managed Care.

What we're reading, September 20, 2016: CDC reports widespread use of powerful antibiotics in hospitals; Gilead Sciences is backing advocates who want states to pay for expensive drugs; and Zika travel advisory lifted in 1 Florida zone.

In a series of interviews with MD Magazine, Yoav Golan, MD, MS, FIDSA, discussed some health risks for patients with acute myeloid leukemia who are experiencing neutropenia.

The Bloomberg American Health Initiative would cover research on obesity, gun violence, environmental threats, adolescent health, and drug addiction.

Evidence has been accumulating that links irregular sleep with chronic disease, but today is the first time the American Heart Association has issued a statement on the topic.

The provision of patient-centered care leads to better engagement between patients and their healthcare teams. One way to encourage patient-centered care is to incorporate patient-reported outcomes into clinical settings.

Using prophylaxis with biosimilar granulocyte colony-stimulating factor can reduce the severity of neutropenia in patients with soft tissue sarcoma.

What we're reading, September 19, 2016: the government update rules on reporting clinical trial findings; hospitals say they aren't receiving discounts for Valeant's heart drugs; and the FDA approved the first treatment for Duchenne muscular dystrophy.

A new national study of adults with commercial health insurance found that although use of what are termed “low-value” medical services is modest, there is potential for considerable cost savings if spending on these services is reduced.

Accountable care organizations are becoming increasingly common in the United States, but they are more likely to be formed in regions of the country with populations that have a higher socioeconomic status.

About 4 million patients need home-based medical care because they are frail, functionally limited, and homebound. New research finds out just how much are the home-based medical care providers geographically concentrated or spread out.

This week, the top managed care stories included news that Risa Lavizzo-Mourey, MD, MBA, will be leaving the Robert Wood Johnson Foundation, a report that obesity rate in the military are also on the rise, and CMS denied Ohio's proposal to charge fees for Medicaid.

Massachusetts achieved near-universal insurance coverage after enacting its own healthcare reform 10 years ago, but gains in improved access to and affordability of care faded over time.

Results for Novo Nordisk’s semaglutide were reported today at the European Association for the Study of Diabetes. A filing for FDA approval is expected before the end of the year.

The American Journal of Managed Care reached out to Daniel F. Hayes, MD, FASCO, 2016-2017 president of the American Society of Clinical Oncology (ASCO), to understand his perception of how the recommendations of the Cancer Moonshot initiative's Blue Ribbon Panel would impact cancer care in the United States.

The report showed a strong connection between states with high rates of inactivity and those with the highest rates of obesity.

Highlights of our peer-reviewed research in the healthcare and mainstream press.

The current issue of Evidence-Based Diabetes Management explores studies and patient access issues surrounding this closely watched inhaled insulin.

Patients with a history of cancer were more likely to suffer from obesity than the general population. This incidence was even greater in patients who were survivors of colorectal and breast cancers.

What we're reading, September 16, 2016: Donald Trump mentions using Medicaid to expand coverage and making birth control available without a prescription; medical marijuana could curb the opioid epidemic; and how rare diseases are becoming more common.

There has been a steady decline in death rates among children and adolescent patients diagnosed with cancer (ages 1 to 19 years), minus gender or racial disparity, between 1999 and 2014, according to a new report from the National Center for Health Statistics.